GlassScriptPhysician profile
Omar F Hadidi
NPI 1194024414
$10,033.51
in general payments reported to CMS, 2019-2025
38 companies · $1,785 in 2025
The $1,785 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $430 · 2021: $891 · 2022: $848 · 2023: $1,860 · 2024: $3,539 · 2025: $1,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,541 · Travel and Lodging: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,540.85 |
| Travel and Lodging | $643.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,357.65 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet, Aveir |
| Boston Scientific Corporation | $1,106.12 | 2019-2025 | Embold Fibered, Avvigo Guidance System, General - Therapies |
| Medtronic, INC. | $1,016.94 | 2023-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $609.90 | 2019-2025 | Lifevest |
| Abiomed | $540.11 | 2022-2025 | Impella |
| Irhythm Technologies, INC. | $429.21 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $365.96 | 2021-2025 | |
| Edwards Lifesciences Corporation | $302.47 | 2023-2025 | Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $250.85 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $222.55 | 2022-2025 | Verquvo |
| Pfizer INC. | $181.79 | 2019-2024 | |
| Endologix LLC | $147.75 | 2025 | Torus Stent Graft System, Endocross Device |
| E.R. Squibb & Sons, L.L.C. | $145.56 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $131.93 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $119.55 | 2019-2024 | Farxiga |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $117.13 | 2021-2024 | Ozempic, Wegovy |
| Penumbra, INC. | $100.67 | 2024 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.84 | 2021-2024 | Jardiance |
| Biotronik INC. | $95.95 | 2024 | Orsiro Mission |
| Esperion Therapeutics, INC. | $95.32 | 2021-2024 | Nexletol |
| Teleflex LLC | $76.12 | 2024-2025 | Manta, Arrow |
| Biosense Webster, INC. | $70.17 | 2025 | Nuvision Ice Catheter |
| Inspire Medical Systems, INC. | $68.18 | 2025 | Inspire |
| Angiodynamics, INC. | $60.82 | 2025 | Alphavac |
| Actelion Pharmaceuticals US, INC. | $53.28 | 2023-2024 | Uptravi, Opsumit |
| Cardiovascular Systems INC. | $44.61 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $27.26 | 2023 | Optimizer |
| Daiichi Sankyo INC. | $27.03 | 2023 | Injectafer |
| Azurity Pharmaceuticals, INC. | $24.26 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $23.54 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $22.87 | 2024 | Arcalyst |
| Medicomp INC | $19.39 | 2022 | |
| Baxter Healthcare | $17.75 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $14.31 | 2024 | |
| Cashflow Solutions, LLC | $14.04 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Chiesi USA, INC. | $13.53 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.10 | 2021 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hadidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.